-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
-
Summary
-
Vir Biotechnology, Inc. annual/quarterly Depreciation, Depletion and Amortization history and growth rate from Q3 2018 to Q1 2024.
- Vir Biotechnology, Inc. Depreciation, Depletion and Amortization for the quarter ending March 31, 2024 was $4.52M, a 19.9% decline year-over-year.
- Vir Biotechnology, Inc. Depreciation, Depletion and Amortization for the twelve months ending March 31, 2024 was $18.3M, a 66.6% increase year-over-year.
- Vir Biotechnology, Inc. annual Depreciation, Depletion and Amortization for 2024 was $14.6M, a 25.2% decline from 2023.
- Vir Biotechnology, Inc. annual Depreciation, Depletion and Amortization for 2023 was $19.5M, a 187% increase from 2022.
- Vir Biotechnology, Inc. annual Depreciation, Depletion and Amortization for 2022 was $6.78M, a 28.5% increase from 2021.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)